source
- Trump announces nine voluntary drug pricing agreements with mid-size biotech firmsOn August 31, 2026, the White House announced that President Donald Trump has secured nine new voluntary drug-pricing agreements with mid-size biotechnology companies. The companies entered the de…
- Industry insiders invited to take Q3 BioPharma Sentiment SurveySignal's Endpoints team is launching the third quarterly BioPharma Sentiment Index (BPSI) survey, a three minute questionnaire that captures industry views. The survey asks participants to share p…